Eurointervention

Papers
(The H4-Index of Eurointervention is 31. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
TAVR under 70: is age just a number?225
International variation in modality and outcomes of left main revascularisation: does it really matter?119
Double-tap to treat paravalvular leak in high-risk annuli99
The conundrum of percutaneous coronary intervention without aspirin: a call for clarity86
In search of the origin of the acronym TAVI75
Transapical transcatheter mitral valve implantation in patients with prior aortic valve replacement: a feasibility report74
Transcatheter left ventriculoplasty74
Should we routinely use ultrasound-guided transfemoral access for coronary procedures? High-quality evidence from an individual participant data meta-analysis66
Development and validation of a scoring system for predicting clinical coronary artery perforation during percutaneous coronary intervention of chronic total occlusions: the PROGRESS-CTO perforation s58
Valve-in-valve transcatheter aortic valve implantation versus repeat surgical aortic valve replacement in patients with a failed aortic bioprosthesis57
Safety of early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study54
Prognostic value of structural and functional coronary microvascular dysfunction in patients with non-obstructive coronary artery disease; from the multicentre international ILIAS registry50
Recanalisation of coronary chronic total occlusions49
Long-term outcomes of measured and predicted prosthesis-patient mismatch following transcatheter aortic valve replacement47
Transcatheter edge-to-edge repair with the PASCAL device for failed MitraClip procedure46
Defer-based non-stenting: a promising approach for STEMI45
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarc43
Incidence and mechanisms of bioprosthetic dysfunction after transcatheter implantation of a mechanically-expandable heart valve42
Hybrid coronary revascularisation: the best or the worst of both worlds?41
Thermodilution-derived temperature recovery time: a novel predictor of microvascular reperfusion and prognosis after myocardial infarction41
   Atrial fibrillation and acute coronary syndrome 40
The “road travelled”: reflections on the transformation of information exchange in a digital age40
One-month DAPT after acute coronary syndrome: too short or not too short?38
Transcatheter edge-to-edge valve repair versus minimally invasive beating-heart surgery of the tricuspid valve: an observational study37
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document36
Twelve-month outcomes of the LuX-Valve for transcatheter treatment of severe tricuspid regurgitation36
Life expectancy of patients with a transcatheter aortic valve and the implications for long-term valve durability data collection35
Redo transcatheter mitral valve replacement in mitral annular calcification35
A sham-controlled randomised trial of pulmonary artery denervation for Group 1 pulmonary arterial hypertension: one-year outcomes of the PADN-CFDA trial32
Early outcomes of transcatheter versus surgical aortic valve implantation in patients with bicuspid aortic valve stenosis32
Outcomes of newly diagnosed atrial fibrillation in patients with acute coronary syndromes31
0.097686052322388